Skip to main content

CLASP IID

CLASP IID

Principal Investigator

Sponsor

Edwards Lifesciences, LLC

The goal of this study is to assess the safety and performance of the PASCAL System in patients with symptomatic degenerative mitral regurgitation (DMR). Up to 300 participants will take part in this randomized study at up to 75 international study centers. Up to 60 patients at AdventHealth Orlando will participate in this study. The goal of this study is to assess the safety and performance of the PASCAL System in patients with symptomatic degenerative mitral regurgitation (DMR). Up to 300 participants will take part in this randomized study at up to 75 international study centers. Up to 60 patients at AdventHealth Orlando will participate in this study.

This study is currently enrolling.